Clinical Trials

Clinical trials web image

A diagnosis of dementia can be distressing for all people concerned: people and their families. Joining a clinical trial to investigate new treatment options can alleviate some of that stress, provide a sense of hope and offer support.

The Dementia Centre’s clinical trials team is staffed by industry-recognised professionals with connections to trial sponsors and leading dementia researchers worldwide. 

Our trials investigate the effectiveness of new drug treatments for people living with early-moderate stage dementias and other related conditions.

Participants may gain access to new treatments, as well as learning more about their condition and how to manage it. There are no costs involved and assistance with travel can be arranged.

 

Our studies are conducted at:

VIC: HammondCare, 261 Wattletree Road Malvern, 3144

 

To discuss trial participation, please contact:

  • Clinical Trial Coordinator VIC
    • Phone (03) 9597 6516
    • Email This email address is being protected from spambots. You need JavaScript enabled to view it. 

 

Find out more

Current drug trials open to participants

Jansenn Automomy Study

A randomised, double-blind, placebo-controlled, parallel-group, multicentre study to assess the efficacy and safety of JNJ-63733657, an anti-tau monoclonal antibody, in participants with Early Alzheimer’s Disease.

NovoNordisk EVOKE plus study

A randomised, double-blind, placebo-controlled, clinical trial investigating the effect and safety of oral semaglutide in participants with early Alzheimer’s disease.

Eli Lilly study

Assessment of safety, tolerability and efficacy or LY3372689 in early symptomatic Alzheimer’s disease.